llrx-royce.blogspot.com
Howes, who also will server as vice president forcorporate development, joinsx Akebia from Serenex. At that firm, he was chieft financial officer and seniotr vice president forcorporate development. “We are extremely pleased to have Ian join He brings a wealth of senior level financial and corporate development experience and leadershiop tothe company,” Dr. Joseph CEO of Akebia, said in a presa release. “We have a number of very exciting programx under wayand Ian’s experiences in capital management, corporatd development and operations will be essential in helping the company successfully move into our next phasw of value creation.” At Durham, N.C.
-base d Serenex, Howes helped generate $75 million in private equith and debt capital and managed the sale of the company to Before that, he was chiefd financial officer at Paradigm Genetics. “Akebia is expectingv important near-term milestones including moving its first product into the clinixc for anemia and preparing to publisnh groundbreaking preclinical results for anadditional program, makinh this a particularly exciting time to join the Howes said in the The Blue Ash-based company was formed in 2007 with programs and asseta licensed from when the consumerf goods maker turned its focus away from in-house drug Cincinnati-based was one of the original
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment